Suzanne Murphy

Suzanne Murphy, MPH, currently serves as the Director of Clinical Compliance and Oversight at Verve Therapeutics since May 2025. Prior to this role, Suzanne held significant positions at Editas Medicine as Director of Clinical Operations, Compliance and Oversight from August 2023 to December 2024, and at Agios Pharmaceuticals as Associate Director, Head of Clinical Monitoring Oversight from December 2017 to July 2023. Additional experience includes roles at Clinical Assistance Programs, Novartis Institutes for BioMedical Research, the National Institutes of Health, Eastern Virginia Medical School, and Children's National Hospital, spanning various aspects of clinical research and operations. Suzanne earned an MPH in Maternal and Child Health from The George Washington University School of Medicine and Health Sciences and a B.S. in Psychology from the University of Florida.